ELI LILLY: LATEST U.S. PHARMA COMPANY TO HALT COVID-19 DRUG TRIALS

Highlights

• Eli Lilly has decided to suspend Phase 3 of its lab-produced anti-body treatment in hospitalized patients over an unspecified incident

• Previously AstraZeneca-University of Oxford developed coronavirus vaccine trials were put on hold after one of its candidates in Britain was diagnosed with an inflammatory condition affecting the spine

• This is a huge setback for the people in the U.S....